Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.
Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.
复制标题
DOI:
10.1002/mus.21683
复制
发表时间:
2010-07
期刊:
影响因子:
3.4
通讯作者:
Bowser, Robert
中科院分区:
文献类型:
--
作者:
Ryberg, Henrik;An, Jiyan;Darko, Samuel;Lustgarten, Jonathan Llyle;Jaffa, Matt;Gopalakrishnan, Vanathi;Lacomis, David;Cudkowicz, Merit;Bowser, Robert
Recent studies using mass spectrometry have discovered candidate biomarkers for amyotrophic lateral sclerosis (ALS). However these studies utilize small numbers of ALS and control subjects. Additional studies using larger subject cohorts are required to verify these candidate biomarkers. Cerebrospinal fluid (CSF) from 100 patients with ALS, 100 disease control and 41 healthy control subjects were examined by mass spectrometry. 61 mass spectral peaks exhibited altered levels between ALS and controls. Mass peaks for cystatin C and transthyretin were reduced in ALS, whereas mass peaks for post-translational modified transthyretin and C-reactive protein (CRP) were increased. CRP levels were 5.84±1.01 ng/mL for controls and 11.24±1.52 ng/mL for ALS subjects as determined by ELISA. This study verified prior mass spectrometry results for cystatin C and transthyretin in ALS. CRP levels were increased in the CSF of ALS patients, and cystatin C level correlated with survival in patients with limb-onset disease. Our biomarker panel predicted ALS with an overall accuracy of 82%.
登录
查看更多内容
影响因子:
11
作者:
O'Toole, O.;Traynor, B. J.;Hardiman, O.
通讯作者:
Hardiman, O.
影响因子:
30.8
作者:
Kaeser, Stephan A.;Herzig, Martin C.;Jucker, Mathias
通讯作者:
Jucker, Mathias
影响因子:
11.2
作者:
Hansson, Sara F.;Simonsen, Anja Hviid;Blennow, Kaj
通讯作者:
Blennow, Kaj
影响因子:
3.4
作者:
Biroccio, A;del Boccio, P;Urbani, A
通讯作者:
Urbani, A
影响因子:
4.4
作者:
Kiernan, Urban A.;Addobbati, Riccardo;Nelson, Randall W.
通讯作者:
Nelson, Randall W.